Fri, May 7, 2021

Swayampakula Ramakanth Maintained (BCYC) at Strong Buy with Increased Target to $39 on, May 7th, 2021

Swayampakula Ramakanth of HC Wainwright & Co., Maintained "Bicycle Therapeutics plc" (BCYC) at Strong Buy with Increased Target from $31 to $39 on, May 7th, 2021.

Swayampakula has made no other calls on BCYC in the last 4 months.



There is 1 other peer that has a rating on BCYC. Out of the 1 peers that are also analyzing BCYC, 0 agree with Swayampakula's Rating of Hold.



This is the rating of the analyst that currently disagrees with Swayampakula


  • Reni Benjamin of "JMP Securities" Initiated at Buy and Held Target at $53 on, Tuesday, April 20th, 2021